下载文档原格式
Product informationISOFLEX TOPAS L 32, L 32 N,Prod. 004130, 004227,enEdition 14.08.2019 [replaces edition 28.01.2019]Benefits for your application–Exceed OEM requirements of -40 °C–Long service life due to high corrosion protection and resistance to oxidation and ageing–Many years of successful use in the automotive industry (specified and approved by most car manufacturers and component suppliers worldwide)DescriptionISOFLEX TOPAS L 32 and L 32 N have been designed for extremely low temperatures. These greases consist of asynthetic hydrocarbon oil and a special lithium soap. ISOFLEX TOPAS L 32 and L 32 N are resistant to ageing and oxidation and provide good corrosion protection as well as water resistance.ISOFLEX TOPAS L 32 N also contains a UV indicator, which ensures quality checking even with minimum quantity lubrication.ApplicationISOFLEX TOPAS L 32 and L 32 N are especially used for the lubrication of small gears used in automotive engineering for electrical adjustment mechanisms, e.g. window lifters, sun roofs, seats, headlamps, fan flaps.Both products have been approved by renowned car manufacturers, such as –Volkswagen VW TL 778 A –Daimler DBL 6827.40 and –Daimler DBL 6827.41.ISOFLEX TOPAS L 32 and L 32 N can also be used for:–guideways, bowden cables, door locks –rolling bearings in small motors, fans, pumps–tooth flanks in plastic/plastic gears (e.g. POM, PA and PBT)or plastic/steel material combinations.Application notesThe lubricant is applied by spatula, brush, grease gun or cartridge.Material safety data sheetsMaterial safety data sheets can be requested via our website . You may also obtain them through your contact person at Klüber Lubrication.ISOFLEX TOPAS L 32, L 32 N Special low-temperature greasesISOFLEX TOPAS L 32, L 32 N,Prod. 004130, 004227,enEdition 14.08.2019 [replaces edition 28.01.2019]Product information。
Options:only for DH-04 and DK-14, see section ݚ:/A = actuator device mounted on side of port B only for DP:/H = adjustable chokes for controlling the main spool shifting time(meter-out to the pilot chambers of the main valve)/H9= adjustable chokes for controlling the main spool shifting time(meter-in to the pilot chambers of the main valve)/R = with check valve on port P/S = main spool stroke adjustment (not available for DP-1*)Valve configuration, see section ݚ0= free, without springs1= spring centered, without detent 3= spring offset external position5= 2 external positions, with detent (only for DH and DK)7= center and external positionsHydraulic operated directional valvesISO 4401 size 06, 10, 16, 25 and 32Table E225-1/EHydraulic operated directional valves are spool type, three or four way, two or three position, designed to operate in oil hydraulic systems.Available with single or double hydraulic actuator.DH-0 = ISO 4401 size 06, flow up to 50 l/min DK-1 = ISO 4401 size 10, flow up to 160 l/min DP-1 = ISO 4401 size 10, flow up to 160 l/min DP-2 = ISO 4401 size 16, flow up to 300 l/min DP-3 = ISO 4401 size 25, flow up to 600 l/min DP-4 = ISO 4401 size 25, flow up to 700 l/min DP-6 = ISO 4401 size 32, flow up to 1000 l/min Max pressure:350 bar for DH-0, DP-1,DP-2, DP-3, DP-6315 bar for DK-1DH-0Type of actuator:4 = single actuator 5 = double actuatorSpool type, see section ݛ1MODEL CODEE225413/A **/*Directional control valve,size:DH-0 = 06DK-1 = 10DP-1 = 10DP-2 = 16DP-3 = 25DP-4 = 25 (high flow)DP-6 = 32Series numberHYDRAULIC CHARACTERISTICS2see note (1)3 (min) 5 (suggested)70Acting the actuator on port A,the hydraulic connections are P →B, A →T, except for spool type 4 and 5 where the con-nections are P →A, B →T.OperationThe spool displacement is achieved by hydraulic pressure on one of the pilot chambers, while the other is unloaded.When pressurizing port X, the port Y has to be directly connected to the tank at null pressure and viceversa.By pressurizing port X, the hydraulic connections are P →A, B →T, except for spool type 4 and 5 where the connections are P →B, A →T.In the spring centered versions the spool is centered by the spring action when both the pilot chambers are unloaded.1) The max pressure on port T has to be not over 50% of pilot pressure.Valve modelMax recommended flow [l/min]Max pressure on port P, A, B[bar]Max pressure on port T (also X, Y for DP)[bar]Minimum pilot pressure[bar]Max recommended pressure on piloting line[bar]3502504250DH-050350DK-1160315DP-1160DP-2300DP-3600DP-4700DP-61000Seals material:omit for NBR (mineral oil & water glycol)PE = FPM3MAIN CHARACTERISTICS OF HYDRAULIC OPERATED DIRECTIONAL VALVESAssembly position / location Any position except for valves type DH-050, DK-150, DP-*50 (without springs) that must be installed withtheir longitudinal axis horizontalSubplate surface finishing Roughness index Ra 0,4 - flatness ratio 0,01/100 (ISO 1101)Ambient temperature-20°C to + 70°CFluid Hydraulic oil as per DIN 51524...535, for other fluids see section ݗRecommended viscosity15 ÷ 100 mm2/s at 40°C (ISO VG 15 ÷ 100)Fluid contamination class ISO 4406 class 21/19/16 NAS 1638 class 10, in line filters of 25 μm (β25 _>75 recommended)Fluid temperature-20°C +60°C (standard seals) -20°C +80°C (/PE seals)4CONFIGURATIONS and SPOOLS valves type DH-*, DK-*NOTES-Spools type 0 and 3 are also available as 0/1 and 3/1, where in centre position oil passage from ports to tank are restricted;-Spools type 1,4 and 5 are also available as 1/1, 4/8 and 5/1. They are properly shaped to reduce water-hammer shocks during the switching;-Spool type 1, 3, 8 and 1/2 for DH-0 and DK-1 are available as 1P, 3P, 8P (only for DH-0), and 1/2P to limit valve leakage.-On request, other type of spools are available.5CONFIGURATIONS and SPOOLS valves type DP-*NOTES-Spools type 0 and 3 are also available as 0/1 and 3/1, where in centre position oil passage from ports to tank are restricted;-Spools type 1,4 and 5 are also available as 1/1, 4/8 and 5/1 (not available for DP-6). They are properly shaped to reduce water-hammer shocks during the switching;-On request, other type of spools are available.6Q/Δp DIAGRAMSDH-0See note and diagrams on table E010 relating the DH* valve from which DH-0* are derivatedDK-1See note and diagrams on table E025 relating the DKE, DKER valve from which DK-1* are derivatedDP-1See note and diagrams on table E085 relating the DPH*-1 valve from which DP-1* are derivatedDP-2See note and diagrams on table E085 relating the DPH*-2 valve from which DP-2* are derivatedDP-3See note and diagrams on table E085 relating the DPH*-3 valve from which DP-3* are derivatedDP-4See note and diagrams on table E085 relating the DPH*-4 valve from which DP-4* are derivatedDP-6See note and diagrams on table E085 relating the DPH*-6 valve from which DP-6* are derivated7DIMENSIONS OF HYDRAULIC OPERATED VALVES ISO 4401 size 06 and 10 [mm]E2258DIMENSIONS OF HYDRAULIC OPERATED VALVES ISO 4401 size 16, 25 and 32 [mm]06/13。
CS-2100i/2000i根据SYSMEX在血栓与止血领域多年积累的经验，为全面满足各类实验室的需求率先开发CS-2100i/2000i。
四种方法学：凝固法/发色底物法/免疫比浊法/聚集法unique!多波长高精度光学检测：5种波长检测提供可靠数据新型智能监测：特有的HIL check 功能排除溶血/黄疸/脂血干扰更多新检测项目的选择：FXIII，vWF:Rco等更可靠的实验室质量保证：SNCS实时在线质控全面满足血栓与止血检测需求！CA-7000以全球最快的分析速度提供全面和高精准的止凝血项目检测结果，仪器集中了凝固法，发色底物法和免疫法于一体，设计高度人性化和智能化，操作简便，成为大规模实验室的首选。
● 多参数测试，500测试/小时高速分析能力● 操作简便，灵活对待各种需求● 优秀的试剂管理系统（SRS）● 安全、实用的系统设计● 大容量的数据管理能力，完整的质控系统CA-1500汇集了当今血栓/止血分析仪最新的各种先进功能于一身，是市场上少见的性能/价格比极高的一台仪器，是大型教学医院，综合医院实验室的首选。
它具有快速处理能力，最快180测试/小时，集多种检测功能于一身：凝固法、发色底物法、免疫法。
具有全能随机组合能力，两种方法测定纤维蛋白质，适合常规大量和急诊使用。
● 拥有高速处理能力、随机测试功能和自动再检查功能● 三种分析方式，包括多规则监视的广泛质控文件和平行线生物分析功能● 卓越的性能可以灵活适应实验室的多样化需求CA-500系列CA-500系列包含了六款机型，设计新颖、符合经济原则，是各中小型实验室开展血栓/止血实验的最佳选择，也是半自动升级到全自动的理想机型。
小型台式仪实用可靠,具备三种检测系统即凝固法、发色底物法、免疫法的自由组合用户可根据需要选择相应机型。
CA-50设计上完全沿用了全自动CA系列的检测原理，锁定人为误差因素的设计确保它有别于其他半自动血凝仪，达到全自动仪器的准确性与重复性效果，四通道即可批量检测又可单独检测，内置质控文件，适用于小标本量实验室使用。
使用说明书Version 21.201/产品概述 02/产品组分03/保存条件04/适用范围05/自备材料06/注意事项07/实验原理与流程概要08/实验流程09/常见问题与解决方案目 录 Contents .................................................................................................... 02.................................................................................................... 02.................................................................................................... 02. (02) (03) (03) (03) (04) (05)*所有商标均属于各自商标所有者的财产。
某些商标并未在全部行政区注册。
01/ 0202/产品组分01/产品概述取1 - 5 ml 过夜培养的菌液，采用优化的SDS-碱裂解法裂解细胞，30 min 可以完成多个样品的抽提工作，提取过程无需酚氯仿抽提、乙醇沉淀等步骤，采用独特的离心吸附柱在高盐、低pH 状态下高效特异的结合溶液中的质粒DNA ，并最大限度的去除蛋白质、基因组、RNA 和其他杂质，最后在低盐、高pH 的洗脱缓冲液将纯净质粒DNA 从硅基质膜上洗脱，每个吸附柱可吸附高达35 μg 的质粒DNA 。
纯化的质粒DNA 可直接用于酶切、PCR 、测序、连接、转化、转染一些常规的传代细胞等生物学实验。
04/适用范围本产品适用1 - 5 ml 过夜培养的菌液；处理低拷贝质粒时，按比例扩大Buffer P1、Buffer P2和Buffer P3的用量，可将菌液量提升至5 -10 ml 。
PRODUCT DATA SHEET Sikaflex®-271 PowerCureVersion 03.01 (04 - 2023), en_AU012001252710001000PRODUCT DATA SHEETSikaflex®-271 PowerCureAccelerated glazing adhesiveTYPICAL PRODUCT DATA (FURTHER VALUES SEE SAFETY DATA SHEET)Chemical base Polyurethane Colour (CQP001-1)BlackCure mechanism Moisture-curing A Density (uncured)1.2 kg/l Non-sag properties (CQP061-1)Very good Application temperature 5 ─ 40 °C Open time (CQP526-1)10 minutes B Early tensile lap-shear strength (CQP046-1)See table 1Shore A hardness (CQP023-1 / ISO 48-4)65Tensile strength (CQP036-1 / ISO 527)7 MPa Elongation at break (CQP036-1 / ISO 527)300 %Tear propagation resistance (CQP045-1 / ISO 34)10 N/mm Tensile lap-shear strength (CQP046-1 / ISO 4587) 5 MPa Service temperature (CQP509-1 / CQP513-1)-40 ─ 90 °C Shelf life9 monthsCQP = Corporate Quality Procedure A Provided by PowerCure B 23 °C / 50 % r.h.DESCRIPTIONSikaflex®-271 PowerCure is an accelerated elastic polyurethane adhesive for glazing and vehicle-glass-replacement applications. Suit-able for bonding materials relevant for direct glazing such as paints, glass, ceramic frits, painted and e-coated surfaces in commercial-vehicle production and repair.Curing of Sikaflex®-271 PowerCure is acceler-ated by Sika’s PowerCure technology which makes it largely independent of atmospheric conditions.PRODUCT BENEFITSAccelerated curing and adhesion build-up ▪Excellent application properties▪Ideal for glass replacement in commercial vehicles▪Low climate dependency of the curing speed with Sika® Booster ▪High mechanical strength ▪Solvent-free▪AREAS OF APPLICATIONSikaflex®-271 PowerCure is designed espe-cially for manual direct-glazing application, and vehicle-glass replacement in commercial vehicles. Thanks to the PowerCure Techno-logy Sikaflex®-271 PowerCure exhibits a fast strength and adhesion build-up.This product is suitable for experienced pro-fessional users only. Tests with actual sub-strates and conditions have to be performed to ensure adhesion and material compatibil-ity.1 / 2CURE MECHANISMSikaflex®-271 PowerCure cures by reaction with moisture provided by the accelerator paste and largely independent from atmo-spheric moisture. For typical strength build up data see table below.Time [h]Tensile lap-shear strength at23 °C [MPa]10.72 3.5Table 1: Strength build-up of Sikaflex®-271 PowerCure CHEMICAL RESISTANCESikaflex®-271 PowerCure is generally resistant to fresh water, seawater, diluted acids and di-luted caustic solutions; temporarily resistant to fuels, mineral oils, vegetable and animal fats and oils; not resistant to organic acids, glycolic alcohol, concentrated mineral acids and caustic solutions or solvents.METHOD OF APPLICATIONSurface preparationSurfaces must be clean, dry and free from grease, oil and dust. Surface treatment de-pends on the specific nature of the substrates and is crucial for a long lasting bond. All pre-treatment steps must be confirmed by pre-liminary tests on original substrates consider-ing specific conditions in the assembly pro-cess.ApplicationSetup the PowerCure Dispenser according to the PowerCure User Manual. If the applica-tion is discontinued for more than 2 minutes, the mixer needs to be replaced.Sikaflex®-271 PowerCure can be processed between 5 °C and 40 °C, but changes in react-ivity as well as application properties need to be considered. The optimum temperature for substrate and adhesive is between 15 °C and 25 °C.The open time is significantly shorter in hotand humid climates. The parts must always bejoined within the open time. As a rule ofthumb, a change of + 10 °C reduces the opentime by half.To ensure a uniform thickness of the bondlineit is recommended to apply the adhesive inthe form of a triangular bead (see figure 1).Figure 1: Recommended bead configurationRemovalUncured Sikaflex®-271 PowerCure can be re-moved from tools and equipment with Sika®Remover-208 or another suitable solvent.Once cured, the material can only be re-moved mechanically. Hands and exposed skinhave to be washed immediately using handwipes such as Sika® Cleaner-350H or a suit-able industrial hand cleaner and water. Donot use solvents on skin.FURTHER INFORMATIONThe information herein is offered for generalguidance only. Advice on specific applicationsis available on request from the Technical De-partment of Sika Industry.Copies of the following publications are avail-able on request:Safety Data Sheets▪General GuidelinesBonding and Sealing with 1-componentSikaflex®▪PowerCure User Manual▪PowerCure Quick Reference Guide▪PACKAGING INFORMATIONPowerCure Pack600 mlBASIS OF PRODUCT DATAAll technical data stated in this document arebased on laboratory tests. Actual measureddata may vary due to circumstances beyondour control.HEALTH AND SAFETY INFORMATIONFor information and advice regarding trans-portation, handling, storage and disposal ofchemical products, users shall refer to the ac-tual Safety Data Sheets containing physical,ecological, toxicological and other safety-re-lated data.DISCLAIMERThe information, and, in particular, the re-commendations relating to the applicationand enduse of Sika products, are given ingood faith based on Sika's current knowledgeand experience of the products when prop-erly stored, handled and applied under nor-mal conditions in accordance with Sika's re-commendations. In practice, the differencesin materials, substrates and actual site condi-tions are such that no warranty in respect ofmerchantability or of fitness for a particularpurpose, nor any liability arising out of anylegal relationship whatsoever, can be inferredeither from this information, or from any writ-ten recommendations, or from any other ad-vice offered. The user of the product musttest the product's suitability for the intendedapplication and purpose. Sika reserves theright to change the properties of its products.The proprietary rights of third parties must beobserved. All orders are accepted subject toour current terms of sale and delivery. Usersmust always refer to the most recent issue ofthe local Product Data Sheet for the productconcerned, copies of which will be suppliedon request.PRODUCT DATA SHEET Sikaflex®-271 PowerCure Version 03.01 (04 - 2023), en_AU 012001252710001000Sika Australia Pty Limited ABN 12 001 342 329 Tel: 1300 22 33 482 / 2。
Promega 公司普洛麦格公司（Promega Corporation）成立于1978年，总部设在美国威斯康星州麦迪逊市，在16个国家设有分公司，在全球范围内还有50多个经销商，服务全球100多个国家。
普洛麦格公司是为生命科学产业提供创新型解决方案和技术支持的领导者。
公司拥有3,000多种产品，致力于提高全球范围内的科学家对基因组学、蛋白质组学、细胞分析、分子诊断和遗传鉴定等领域的认知。
普洛麦格产品不仅被生命科学研究者用于对生物学基本问题的理论研究，也被广泛应用于应用科学领域，以帮助诊断、疾病治疗、发现新的治疗方法及应用遗传和DNA测试进行人类遗传鉴定。
普洛麦格公司在多个重要领域拥有重要知识产权和许可，包括：●生物发光，包括基因工程改造的荧光素酶、荧光素酶载体和底物●短串联重复（STR）分析用于基于STR分析的细胞系鉴定、人类遗传鉴定、细胞和组织鉴定及混合样本检测●Halo Tag®蛋白标记和捕获技术微卫星不稳定性及DNA 错配修复微卫星是短串联重复DNA 序列，长度为1-6个碱基对。
这些重复序列广泛存在于基因组中，并且由于其在基因座位点串联重复次数不同，这些重复序列的长度在不同个体中经常有差异。
微卫星标志物可以用于检测微卫星不稳定性（基因组不稳定性的一种）。
微卫星不稳定（Microsatellite Instability ，MSI ）是微卫星等位基因长度的改变，这种改变是由于DNA 复制过程中重复单元的插入或删除以及DNA 错配修复系统纠错失败造成的。
微卫星是短串联重复DNA序列，长度为1-6个碱基对。
这些重复序列广泛存在于基因组中，并且由于其在每一基因座位点串联重复次数不同，这些重复序列的长度在不同个体中经常有差异。
微卫星标志物可以用于检测微卫星不稳定性（基因组不稳定性的一种）。
微卫星不稳定（Microsatellite Instability，MSI）是微卫星等位基因长度的改变，这种改变是由于DNA复制过程中重复单元的插入或删除以及DNA错配修复系统纠错失败造成的。
inhalation solution 英文说明书Inhalation Solution**产品简介：**This Inhalation Solution is a medical preparation designed for administration via inhalation, providing targeted and rapid therapeutic effects to the respiratory system. It is formulated with carefully selected active ingredients and excipients to ensure optimal efficacy and safety in managing various respiratory conditions.**产品用途：**This Inhalation Solution is indicated for the treatment and management of respiratory disorders such as asthma, chronic obstructive pulmonary disease (COPD), bronchitis, and other conditions characterized by bronchoconstriction, inflammation, or excessive mucus production. It may also be used for prophylactic purposes in individuals prone to respiratory exacerbations.**成分与规格：**The Inhalation Solution contains the following active ingredients: (insert specific drug names and concentrations). It is available in (insert volume, e.g.,20ml) multidose vials, each containing a preservative-free formulation for multiple uses.**用法用量：**Administer the Inhalation Solution using a suitable nebulizer device according to the manufacturer's instructions. The recommended dose is (insert specific dose and frequency, e.g., 2.5mg twice daily). Adjustments may be necessary based on individual patient response and physician guidance. Ensure proper cleaning and maintenance of the nebulizer equipment to maintain product effectiveness and hygiene.**注意事项：**1. **Allergic Reactions**: Discontinue use immediately if signs of allergic reactions such as hives, difficulty breathing, or swelling occur. Seek medical attention promptly.2. **Cardiovascular Conditions**: Use with caution in patients with cardiovascular diseases, particularly those with arrhythmias or hypertension, as certain ingredients may affect heart function.3. **Concomitant Medications**: Inform your healthcare provider about all medications you arecurrently taking, including over-the-counter drugs, herbal supplements, and aerosolized therapies, as potential interactions may affect treatment efficacy or increase side effects.4. **Pregnancy & Lactation**: Consult your physician before using this Inhalation Solution if you are pregnant, planning to become pregnant, or breastfeeding, as its safety in these situations has not been established.**副作用与不良反应：**Common side effects may include throat irritation, coughing, and transient taste alterations. Less frequently, users may experience tremors, palpitations, or paradoxical bronchospasm. Report any persistent or severe adverse reactions to your healthcare provider.**存储条件与有效期：**Store the Inhalation Solution at room temperature (15-25°C), avoiding direct sunlight and moisture. Keep out of reach of children. Do not use beyond the expiration date printed on the packaging.**废弃处理：**Dispose of unused or expired Inhalation Solution and empty containers in accordance with local waste disposalregulations. Do not flush down the toilet or pour into drains.**制造商信息：**This Inhalation Solution is manufactured by (insert company name) and distributed by its authorized representatives. For further information, please refer to the package insert or contact the manufacturer directly.**重要提示：**This product is a prescription medication. Always use under the guidance of a qualified healthcare professional. Adhere to the prescribed dosage and administration schedule. Do not alter, discontinue, or self-prescribe without consulting your physician.---**Product Name:**Inhalation Solution**Product Introduction:**This Inhalation Solution is a medicinal preparation tailored for inhalational administration, delivering targeted and swift therapeutic benefits to the respiratory system. It incorporates meticulously chosen active substances and excipients to guarantee supreme efficacyand safety in addressing diverse respiratory ailments.**Product Usage:**This Inhalation Solution is intended for treating and managing respiratory disorders such as asthma, chronic obstructive pulmonary disease (COPD), bronchitis, and other conditions marked by bronchoconstriction, inflammation, or excessive mucus secretion. It can also serve prophylactic purposes in individuals susceptible to respiratory exacerbations.**Ingredients & Specifications:**The Inhalation Solution comprises the following active ingredients: (insert specific drug names and concentrations). It comes in (insert volume, e.g., 20ml) multidose vials, each filled with a preservative-free formula for multiple applications.**Usage & Dosage:**Administer the Inhalation Solution utilizing an appropriate nebulizer device in accordance with the manufacturer's guidelines. The suggested dose is (insert specific dose and frequency, e.g., 2.5mg twice daily). Adjustments might be needed based on individual patient response and physician advice. Ensure thorough cleaningand upkeep of the nebulizer equipment to preserve product efficiency and cleanliness.**Precautions:**1. **Allergic Reactions**: Cease usage immediately upon manifestation of allergy symptoms like hives, breathing difficulties, or swelling. Promptly seek medical assistance.2. **Cardiovascular Conditions**: Exercise caution when using in patients with cardiovascular diseases, especially those with arrhythmias or hypertension, as some ingredients could impact cardiac function.3. **Concurrent Medications**: Instruct your healthcare provider about all medicines you are currently taking, encompassing OTC drugs, herbal supplements, and aerosol therapies, as potential interactions may influence treatment effectiveness or escalate side effects.4. **Pregnancy & Lactation**: Consult your physician prior to using this Inhalation Solution if you are pregnant, planning pregnancy, or nursing, since its safety in such circumstances remains unestablished.**Side Effects & Adverse Reactions:**Typical side effects may involve throat discomfort,coughing, and temporary taste changes. Less commonly, users might encounter tremors, palpitations, or paradoxical bronchospasm. Report any persistent or severe adverse responses to your healthcare provider.**Storage Conditions & Expiration:**Store the Inhalation Solution at room temperature (15-25°C), steering clear of direct sunlight and moisture. Keep away from children's reach. Do not use post the expiration date inscribed on the packaging.**Disposal Instructions:**Dispose of unused or expired Inhalation Solution and empty containers in line with local waste disposal regulations. Do not flush down the toilet or pour into sinks.**Manufacturer Information:**This Inhalation Solution is produced by (insert company name) and distributed through its authorized agents. For more details, kindly refer to the package insert or contact the manufacturer directly.**Important Reminder:**This product is a prescription medicine. Always utilize under the supervision of a qualified healthcarepractitioner. Adhere strictly to the prescribed dosage and administration schedule. Do not modify, discontinue, or self-prescribe without consulting your physician.。
